The New York Genome Center (NYGC) officially launched its scientific and clinical consortium of academic and industry leaders focused on harnessing genomics to advance the understanding and treatment of disease. The announcement was made at the recent NYGC's inaugural scientific symposium with New York City Mayor Michael Bloomberg speaking at a ribbon cutting ceremony.
NYGC's new 170,000 square foot research facility in Manhattan will bring together leaders of 16 member institutions to discuss the importance of genomics research for the detection, diagnosis and treatment of human disease.
"The opening of the New York Genome Center is a major achievement in the City's ongoing efforts to advance the bioscience sector in New York City - part of our commitment to diversify the city's economy and create jobs," said Bloomberg. "The Genome Center's new facility and its groundbreaking approach to collaboration will help solve some of medicine's most challenging problems by bringing together the city's best academic and clinical institutions."
NYGC is an independent non-profit organization that leverages the collaborative resources of leading academic medical centers, research universities, as well as pharmaceutical, biotech, and technology companies. The vision of NYGC is to transform medical research and clinical care in New York and beyond through the creation of one of the largest genomics research facilities in North America, integrating sequencing, bioinformatics, data management and genomics research.
NYGC represents an unprecedented sharing of data and resources among premier institutions, which will dramatically increase the quality and speed of research outcomes to advance clinical care. The collaborative power of NYGC's members will help nurture scientific advances leading to accelerate the development of new diagnostics and treatments for human diseases, and provide an engine for life science commercialization in the region.
NYGC's twelve Institutional Founding Members include the Albert Einstein College of Medicine, Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medical College, The Jackson Laboratory, Memorial Sloan-Kettering Cancer Center, Mount Sinai Medical Center, New York-Presbyterian Hospital, New York University/NYU School of Medicine, North Shore-LIJ Health System, The Rockefeller University and Stony Brook University. In addition to the American Museum of Natural History, NYGC Associate Members include the Hospital for Special Surgery in Manhattan, Roswell Park Cancer Institute in Buffalo, N.Y., and The New York Stem Cell Foundation.
In addition to its scientific and research mission, the New York Genome Center is also committed to educating researchers, clinicians, students, and the general public through lectures and events on topics ranging from the latest advances in sequencing and bioinformatics to the future of genomics and the accompanying public policy and ethical considerations.
To date, NYGC has raised over $140 million in funds from its Institutional Founding Members, from philanthropies such as the Simons Foundation, the Alfred P. Sloan Foundation, and Bloomberg Philanthropies, and from strategic relationships, including the New York City Economic Development Corporation, the Partnership Fund for New York City, and New York State's Empire State Development Corporation.